(Q37801264)

23 August 2017

Molecular mechanisms of metastasis in breast cancer--clinical applications (English)

1 reference

23 August 2017

2

1 reference

23 August 2017

Michal Mego

1

1 reference

PubMed ID

20956980

23 August 2017

Massimo Cristofanilli

series ordinal

3

1 reference

PubMed ID

20956980

23 August 2017

language of work or name

English

0 references

publication date

19 October 2010

1 reference

Nature Reviews Clinical Oncology

23 August 2017

1 reference

23 August 2017

7

1 reference

23 August 2017

12

1 reference

23 August 2017

693-701

1 reference

23 August 2017

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Molecular portraits of human breast tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Future of personalized medicine in oncology: a systems biology approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Prognostic and predictive factors revisited

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Multivariate analysis of prognostic factors in metastatic breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Circulating tumor cells and biomarkers: implications for personalized targeted treatments for metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Seeding and propagation of untransformed mouse mammary cells in the lung

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Dissemination and growth of cancer cells in metastatic sites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Mechanisms of motility in metastasizing cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Plasminogen activation and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

New functions for the matrix metalloproteinases in cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Collective cell migration in morphogenesis, regeneration and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Plasticity of cell migration: a multiscale tuning model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Epithelial-mesenchymal transitions in development and pathologies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Tumor progression: Small GTPases and loss of cell-cell adhesion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Microenvironmental regulation of metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Involvement of chemokine receptors in breast cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

The metastatic niche: adapting the foreign soil

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Warfarin for cancer prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Cancer stem cells, self-seeding, and decremented exponential growth: theoretical and clinical implications.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Tumor self-seeding by circulating cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

An overview of epithelio-mesenchymal transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

The epithelial-mesenchymal transition generates cells with properties of stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Epithelial-to-mesenchymal transitions and circulating tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Snail and E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Elevated tissue factor procoagulant activity in CD133-positive cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Epithelial-mesenchymal transition and cell cooperativity in metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Breast cancer, stem/progenitor cells and the estrogen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Systemic spread is an early step in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Migration rules: tumours are conglomerates of self-metastases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Detection of mutations in EGFR in circulating lung-cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Isolation of rare circulating tumour cells in cancer patients by microchip technology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

High speed detection of circulating tumor cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.171

A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells.

31 March 2020

1 reference

12 December 2020

Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors

1 reference

12 December 2020

Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation

1 reference

12 December 2020

Quantitation of cell shedding into efferent blood of mammary adenocarcinoma

1 reference

12 December 2020

Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine

1 reference

12 December 2020

Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer

1 reference

12 December 2020

Signalling mechanisms of anoikis

1 reference

12 December 2020

New insights into the pathogenesis of breast cancer metastasis

1 reference

12 December 2020

Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells.

1 reference

12 December 2020

Apoptosis: an early event in metastatic inefficiency

1 reference

12 December 2020

10.1038/NRCLINONC.2010.171

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

20956980